20332 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole 1,3-Diazoles Imidazole-alkanecarboxylic acids, e.g. histidine
Composition Comprising Non-Phosphorylated Tryptamine
#2WEIGHT LOSS SUPPLEMENT COMPOSITION
#3COMPOSITIONS AND METHODS FOR TREATING HOMOCYSTINURIA AND OTHER CONDITIONS
#4METHOD AND COMPOSITION FOR PROTECTING OR IMPROVING OVARIAN FUNCTION IN MAMMALS
#5L-ERGOTHIONEINE-GOLD NANOPARTICLES AND PREPARATION METHOD AND APPLICATION THEREOF
#6PHARMACEUTICAL FORMULATIONS
#7PHARMACEUTICAL FORMULATIONS
#8PROBIOTIC COCKTAIL MEDICAL FOOD TO ENHANCE L-DOPA STABILITY AND REDUCE SIDE EFFECTS IN PARKINSONS DISEASE
#9USING PROBIOTIC MIXTURE FORMULAS ATTENUATE NEURODEGENERATIVE DISEASES PROGRESSION
#10COMPOSITIONS AND METHODS FOR AMELIORATING SYMPTOMS ASSOCIATED WITH INFLAMMATORY SKIN DISORDERS
#11TRANSDERMAL DELIVERY FORMULATIONS
#12COMPOSITIONS AND METHODS FOR PROMOTING BRAIN HEALTH
#13METHOD AND COMPOSITION TO REDUCE OR INHIBIT ADVANCED GLYCATION END-PRODUCTS
#14FIBRINOGEN AND THROMBIN SOLUTIONS FOR A FIBRIN SEALANT AND FIBRIN SEALANT KIT
#15COMPOSITIONS FOR DRINKING WATER
#16COMPOSITION CONTAINING AMINO ACIDS CAPABLE OF MODULATING THE IL-6 EXPRESSION
#17METHODS AND CHEMICAL COMPOSITIONS FOR TREATING SKIN CONDITIONS BY PROVIDING LONG LASTING SKIN PH CONTROL FOR IMPROVING SKIN BARRIER FUNCTION
#18METHODS AND CHEMICAL COMPOSITIONS FOR TREATING SKIN CONDITIONS BY PROVIDING LONG LASTING SKIN PH CONTROL FOR IMPROVING SKIN BARRIER FUNCTION
#19EYE CARE COMPOSITION CONTAINING L-ERGOTHIONEINE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#20FEED FOR ANADROMOUS FISH, METHOD FOR PRODUCING IT, METHOD OF INCREASING SEAWATER TOLERANCE, GROWTH AND FEED INTAKE OF ANADROMOUS FISH, FISH FEED FOR USE IN PREVENTING OR REDUCING SEVERITY OF CATARACTS
#21SALTS OF AN ANTIOXIDANT AND CRYSTALLINE FORMS THEREOF
#22COMBINATION OF DIHYDROBERBERINE AND ERGOTHIONEINE TO REDUCE OR INHIBIT ADVANCED GLYCATION END-PRODUCTS
#23UROLITHIN COMBINATIONS
#24FORMULATIONS FOR PERSONALIZED METHODS OF TREATMENT
#25USE OF ERGOTHIONEINE FOR ANTI-AGING
#26THERAPEUTIC OR PROPHYLACTIC AGENT FOR COVID19 WHICH COMPRISES SELENONEINE
#27Methods for Targeting Cancer Cells Using Amino Acids
#28METHOD AND COMPOSITION FOR IMPROVING OR MAINTAINING SKIN HEALTH OF MAMMALS
#29BIOACTIVE FLUID COMPOSITIONS
#30BIOACTIVE FLUID COMPOSITIONS
#31MEDICATED EYELID CLEANSING COMPOSITIONS
#32PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS WITH A COMBINATION OF AMINO ACIDS AND ITS USE IN DISEASES CHARACTERIZED BY LIPID ACCUMULATION IN TISSUES
#33METHOD OF ADMINISTRATION AND TREATMENT
#34Compositions Comprising One or More (Bio)-Alkanediols with Antioxidants
#35METHODS AND CHEMICAL COMPOSITIONS FOR TREATING SKIN CONDITIONS BY PROVIDING LONG LASTING SKIN PH CONTROL FOR IMPROVING SKIN BARRIER FUNCTION
#36USE OF L-ERGOTHIONEINE FOR ALLEVIATING AND PREVENTING AGE-RELATED LENS DEGENERATION
#37ARTIFICIAL OXYGEN CARRIER BLOOD PRODUCT
#38TRADITIONAL CHINESE MEDICINE COMPOSITION AND PREPARATION METHOD AND APPLICATION THEREOF
#39AMINO ACID COMPOSITIONS
#40AMINO ACID COMPOSITIONS
#41AMINO ACID COMPOSITIONS
#42AMINO ACID COMPOSITIONS
#43AMINO ACID COMPOSITIONS
#44AMINO ACID COMPOSITIONS
#45AMINO ACID COMPOSITIONS
#46PHARMACEUTICAL FORMULATIONS
#47THIOSTREPTON-INSPIRED COMPOUNDS FOR TREATMENT OF CANCER AND PREPARATION THEREOF
#48COMMENSAL SIGNALLING COMPOUNDS FOR TREATING OR PREVENTING MICROBIOME DYSFUNCTION IN THE SKIN OR MOUTH
#49DAPTOMYCIN FORMULATIONS
#50COMPOSITION CONTAINING ERGOTHIONEINE FOR SUPPRESSING OR PREVENTING INNER EAR HEARING LOSS
#51COMPOSITIONS FOR TREATING ACNE AND DERMATOLOGICAL CONDITIONS
#52COMPOSITION, METHOD FOR MICROORGANISM GROWTH SUPPRESSION IN COMPOSITION FOR ORAL USE, AND AGENT FOR POTENTIATION OF MICROORGANISM-GROWTH-SUPPRESSING EFFECT OF QUERCETIN OR GLYCOSIDE THEREOF
#53USE OF ERGOTHIONEINE TO SUPPRESS DELETERIOUS EFFECTS OF SENESCENCE
#54Use of Ergothioneine for Enhancing Glutathione Level
#55Mushroom Spore, Cannabinoid, and Specified Compositions
#56USE OF L-ERGOTHIONEINE TO AMELIORATE AND PREVENT AGE-RELATED VITREOUS DEGENERATION
#57PERSONALIZED MODULATION THERAPY FOR CANCER
#58COMPOSITION FOR INHIBITING HISTAMINE-N-METHYLTRANSFERASE
#59COMPOSITION CONTAINING SESAMIN AND ERGOTHIONEINE OR SALT THEREOF
#60COMPOSITION AND METHOD TO REDUCE LIVER FAT AND CIRCULATING TRIACYLGLYCEROLS
#61Compositions and Methods for Preventing or Improving Premature Skin Aging
#62PROTEIN HYDROLYSATES
#63METHODS FOR EXTENDING THE LIFESPAN OF CELLS AND ORGANISMS
#64COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY CONDITIONS
#65COMPOSITIONS OF ALPHA-2 ANTAGONISTS AND METHODS AND USES THEREOF
#66METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING NEURODEGENERATIVE DISEASES
#67L-ERGOTHIONEINE AND USES THEREOF
#68PARENTERAL NUTRITION CONTAINING TRACE ELEMENTS
#69Acute treatment and rapid treatment of headache using anti-CGRP antibodies
#70Carnosine Analogs for Use in the Treatment of Metabolic Disorders
#71Method and Composition for Mimicking Caloric Restriction by Administration of Ergothioneine
#72Treatment of headache using anti-CGRP antibodies
#73COMPOSITIONS AND METHODS FOR THE REDUCTION OR TREATMENT OF INSULIN RESISTANCE AND METABOLIC CONDITIONS
#74RUMEN-PROTECTED COMPOSITIONS AND METHODS OF MAKING THE SAME
#75COMPOSITION FOR INCREASING LEUKOCYTES AND/OR BASOPHILS
#76COMPOSITION AND METHOD FOR ENHANCING MITOCHONDRIAL BIOGENESIS AND ACTIVATING PGC-1A
#77COMPOSITION FOR PROMOTING LIPOLYSIS
#78COMPOSITIONS FOR PRE-SURGICAL NUTRITIONAL SUPPLEMENTS
#79SYNERGISTIC MODULATORS OF ALPHA-DICARBONYL DETOXIFICATION AND THEIR USE FOR INDUCING WEIGHT LOSS AND THE TREATMENT OF DIABETIC PATHOLOGIES
#80ANTI-ANXIETY COMPOSITION
#81COMPOSITION FOR INCREASING RED BLOOD CELLS AND/OR HEMOGLOBIN
#82Treatment of autism spectrum disorders with ergothioneine, selenoneine, or combinations thereof
#83COMPOSITION FOR AMELIORATING OR SUPPRESSING DECLINE OF KIDNEY FUNCTIONS
#84ORALLY ADMINISTERED COMPOSITIONS FOR CANCER TREATMENT
#85COMPOSITION FOR IMPROVING BLOOD CHOLESTEROL LEVEL
#86COPPER HISTIDINATE COMPOSITIONS AND USES THEREOF
#87RUMEN-PROTECTED COMPOSITIONS AND METHODS OF MAKING THE SAME
#88Compositions for treating acne and dermatological conditions
#89THERAPY BASED ON SYNTHETIC LETHALITY IN SWI/SNF COMPLEX-DYSFUNCTION CANCER
#90Use of L-ergothioneine to ameliorate and prevent age-related vitreous degeneration
#91COMPOSITION FOR STIMULATING IMMUNE CELL METABOLISM
#92TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS BY INTRANASAL ADMINISTRATION OF IMMUNOGLOBULIN G
#93COMPOSITIONS AND METHODS USING AT LEAST ONE GLYCINE OR DERIVATIVE THEREOF AND AT LEAST ONE LARGE NEUTRAL AMINO ACID AND/OR CATIONIC AMINO ACID OR PRECURSOR THEREOF
#94COMPOSITION FOR IMPROVING OR PREVENTING IRON DEFICIENCY ANAEMIA
#95METHODS FOR AMELIORATING AND PREVENTING AGE-RELATED MUSCLE DEGENERATION
#96COMPOSITIONS FOR TREATING FUNGAL AND BACTERIAL BIOFILMS AND METHODS OF USING THE SAME
#97ACUTE TREATMENT AND RAPID TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES
#98Daptomycin formulations
#99TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES
#100COMPOSITIONS COMPRISING PEDF-DERIVED SHORT PEPTIDES (PDSP) AND USES THEREOF
#101CELLULAR HEALTH NUTRITIONAL PRODUCT
#102A COMPOSITION FOR USE IN THE TREATMENT OF INFERTILITY
#103COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS AND ALLEVIATING FATIGUE
#104Method of administration and treatment
#105Topical composition for destroying, in vivo, an external hyperplastic tissue, such as, but not limited to, a viral skin lesion, such as, but not limited to, a viral wart
#106METHODS AND COMPOSITIONS FOR NUTRITIONAL SUSTENANCE AND WASTE SCAVENGING IN TISSUE INJURIES AND WOUNDS
#107Vaginal care compositions and methods of improving vaginal health
#108LYOPHILIZED PHARMACEUTICAL COMPOSITIONS OF COPPER HISTIDINATE
#109FERMENTED COMPOSITION
#110REACTIVATION OF mTOR IN ACUTE KIDNEY INJURY (AKI)
#111ADMINISTRATION OF R-BETA-HYDROXYBUTYRATE AND RELATED COMPOUNDS IN VETERINARY APPLICATIONS
#112METHODS OF NORMALIZING AMINO ACID METABOLISM
#113Compositions and Methods for Treatment of Prediabetes
#114COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF CONDITIONS RELATED TO THE QUALITY OF AGING AND LONGEVITY
#115Compositions comprising one or more (bio)-alkanediols with antioxidants
#116NUTRITION FORMULATION
#117Method for improving eye conditions
#118Method for Improving Eye Condition
#119Compositions comprising one or more (bio)-alkanediols with antioxidants
#120USE OF ERGOTHIONEINE FOR EXTENDING LIFESPAN OR IMPROVING HEALTHSPAN
#121FIBRINOGEN AND THROMBIN SOLUTIONS FOR A FIBRIN SEALANT AND FIBRIN SEALANT KIT
#122METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING VAGUS NERVE ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS
#123SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND HISTIDINE
#124COMPOSITIONS CONTAINING AMINO ACIDS AND METHODS OF USING SUCH COMPOSITIONS FOR TREATING SARCOPENIA
#125L-ERGOTHIONEINE-CONTAINING COMPOSITION
#126PHARMACEUTICAL LIQUID COMPOSITION HAVING INCREASED STABILITY
#127Method of Treating Diseases
#128COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER DISEASES AND DISORDERS
#129FORMULATIONS OF POLYBASIC DRUGS TO REDUCE MULTI-ORGAN TOXICITY
#130GLP-1 COMPOSITIONS AND USES THEREOF
#131AMINO ACID COMPOSITIONS AND METHODS FOR MUSCLE AND MYOTUBE MODULATION
#132Methods and uses of microbiome compositions, components, or metabolites for treating neurodegenerative diseases
#133PHARMACEUTICAL FORMULATIONS
#134COMPOSITIONS COMPRISING AMINO ACIDS FOR USE IN THE PREVENTION AND TREATMENT OF CHEMOTHERAPY SIDE EFFECTS
#135COMPOSITIONS AND METHODS INVOLVING AMINO ACIDS FOR THE TREATMENT OF FAT INFILTRATIONS IN MUSCLE
#136Amino acid compositions and methods for the treatment of post-acute sequelae of COVID-19
#137Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients
#138Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients
#139COMPOSITION FOR SLEEP IMPROVEMENT COMPRISING ERGOTHIONEINE OR SALT THEREOF
#140COMPOSITIONS AND METHODS EXCLUDING OR WITH REDUCED GLUTAMINE FOR THE TREATMENT OF HEMOGLOBINOPATHIES AND THALASSEMIAS
#141COMPOSITIONS AND METHODS FOR GLUTATHIONE ENHANCEMENT FOR USE IN BRAIN HEALTH
#142APPLICATION OF COMPOUND AMINO ACIDS IN PREPARATION OF MEDICAMENT FOR IMPROVING SENSITIVITY OF BACTERIA TO ANTIBIOTICS
#143DIETARY SUPPLEMENT
#144METHODS AND COMPOSITIONS RELATED TO THE USE OF ERGOTHIONEINE
#145TUCARESOL DERIVATIVES AND USES THEREOF
#146Compositions for therapy and health containing amino acids with bitter taste
#147MODIFIED RELEASE ORALLY ADMINISTERED AMINO ACID FORMULATIONS
#148LYOPHILIZED COMPOSITION COMPRISING (S)-ISOPROPYL 2-((S)-2-ACETAMIDO-3-(1H-INDOL-3-YL)PROPANAMIDO)-6-DIAZO-5-OXOHEXANOATE FOR INTRAVENOUS ADMINISTRATION AND THE USE THEREOF
#149Method of treatment for hair loss
#150Compositions for treating fungal and bacterial biofilms and methods of using the same
#151Nutritional Composition for Improving Sleep
#152ENHANCED NITRATE, ELEMENTAL METAL, AND AMINO ACID COMPOSITIONS AND METHODS OF USE
#153PROTEIN HYDROLYSATES
#154ERGOTHIONEINE, S-METHYL-ERGOTHIONEINE, AND USES THEREOF
#155Compositions and methods for increasing muscle mass and strength, treating skin, reducing wear and degradation from aging and exposure and improving recovery from stress such as exercise and trauma
#156PARENTERAL NUTRITION FORMULATION WITH OPTIMIZED AMINO ACID AND GLUCOSE CONTENT
#157Composition for stimulating muscle growth, repair, and maintenance
#158NUTRITION COMPOSITION
#159Composition for increasing skin thickness
#160INJECTABLE COMPOSITION FOR INDUCING LIPOLYSIS AND METHOD USING THE SAME
#161Formulations for personalized methods of treatment
#162Compositions of Glycerol and /or Non-Toxic Amino Acids for Inhibiting and Destroying Biofilm, including Related Methods
#163COMPOSITIONS COMPRISING AMINO ACIDS FOR USE AND TREATMENT OF CENTRAL NERVOUS SYSTEM INJURIES
#164Histidine and/or Histidine Derivative for the Treatment of Inflammatory Skin Diseases
#165COMPOSITIONS AND METHODS FOR TREATING HOMOCYSTINURIA AND OTHER CONDITIONS
#166Food Supplement For Improving Sports Performance
#167Balanced amino acid formulation
#168Compositions and methods for providing health benefits in an animal
#169Method of administration and treatment
#170SYMBIOTIC SUPPLEMENT FORMULATION FOR IMPROVING INTESTINAL MICROBIOTA
#171Method of administration and treatment
#172Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy
#173Method of administration and treatment
#174PROPHYLACTIC AGENT FOR SPONTANEOUS CANCERS
#175USE OF CHROMIUM HISTIDINATE FOR TREATMENT OF CARDIOMETABOLIC DISORDERS
#176Method of administration and treatment
#177SYNBIOTIC COMPOSITION FOR TREATMENT OF INFECTIONS IN ALLERGIC PATIENTS
#178METHOD OF ADMINISTRATION AND TREATMENT
#179METHOD OF ADMINISTRATION AND TREATMENT
#180PARENTERAL NUTRITION CONTAINING TRACE ELEMENTS
#181Composition for treating burn wounds
#182VEGF Antagonist Formulations
#183USE OF HISTIDINE, GLYCINE AND OTHER AMINO ACIDS FOR PREVENTING INSULIN RESISTANCE AND/OR DIABETES
#184SEMI-SOLID ANTI-HISTAMINE COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF
#185MANAGEMENT OF RISK OF CATION OVERLOAD AND ELECTROLYTE IMBALANCE WITH TOPICALLY APPLIED BUFFERS
#186Synergistic nutritional compositions for treating seizures and chronic inflammatory diseases
#187Compositions for treating acne and dermatological conditions
#188COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES AND THALASSEMIAS
#189Compositions and methods for the treatment of fat infiltration in muscle
#190Edible High Nutrient Density Composite and the Use for Reduction and Management of Human Hypertension
#191COMPOSITION OF NUTRITION SUPPLEMENTATION FOR NUTRITIONAL DEFICIENCIES AND METHOD OF USE THEREFORE
#192COMPOSITIONS AND METHODS FOR THE REDUCTION OR TREATMENT OF INSULIN RESISTANCE AND METABOLIC CONDITIONS
#193ZINC-CONTAINING, WATER-SOLUBLE POLYGLUTAMIC ACID COMPLEX COMPOSITION
#194NUTRITIONAL COMPOSITIONS FOR ENHANCEMENT OF MUSCLE PERFORMANCE
#195HAIR CARE CONDITIONING COMPOSITION COMPRISING HISTIDINE
#196VEGF Antagonist Formulations
#197HEAT-STABLE DRY POWDER PHARMACEUTICAL COMPOSITIONS AND METHODS
#198METHOD OF ADMINISTRATION AND TREATMENT
#199CARDIOPROTECTIVE AMINO ACID FORMULATION
#200Method of administration and treatment
#201MUSCLE DIFFERENTIATION-PROMOTING ACTIONS OF ERGOTHIONEINE, ASCORBIC ACID 2-GLUCOSIDE, ASCORBIC ACID, AND COMBINATION THEREOF
#202Treatment of central nervous system disorders by intranasal administration of immunoglobulin g
#203Inhibitors of receptor interacting protein kinase I for the treatment of disease
#204Composition for the Modulation of Circadian Rhythmicity and Sleep Quality
#205Prevention or remediation composition for dementia or depression
#206Citrate buffered VEGF antagonist formulations
#207Pharmaceutical or cosmetic composition for preventing or treating hair loss or promoting hair growth
#208Parenteral nutrition formulation with optimized amino acid and glucose content
#209COMPOSITION AND METHODS
#210Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients
#211FORMULATION FOR USE IN THE TREATMENT OF UREMIC PRURITUS
#212Ergothioneine compositions and methods for maintaining and/or increasing vitamin C levels in cells and organisms
#213Composition for enhancing cognitive function, composition for remedying anxiety symptoms, and composition for suppressing cerebral atrophy
#214Biomedical composition for skin care and/or maintenance and delaying and/or inhibiting skin aging and the use thereof
#215HD acid concentrate with amino acids
#216Inhibitors of influenza virus replication and uses thereof
#217Method of administration and treatment
#218Composition for stimulating muscle growth, repair, and maintenance
#219Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
#220Treatment of headache using anti-CGRP antibodies
#221Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory Tract
#222Amino acid compositions
#223Compositions and methods for the treatment of fat infiltration in muscle
#224OVOTIOLS FOR THE TREATMENT OF CHRONIC LOW-GRADE SYSTEMIC INFLAMMATION (CLGSI) AND RELATED DISEASES
#225Daptomycin formulations
#226Use of amino acid supplementation for improved muscle protein synthesis
#227Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases
#228Compositions and methods for preventing/treating metabolic syndrome
#229Stable, highly pure L-cysteine compositions for injection and methods of use
#230Synergistic compositions of bioactive agents for optimizing cellular health
#231Compositions for treating fungal and bacterial biofilms and methods of using the same
#232Acute treatment and rapid treatment of headache using anti-CGRP antibodies
#233ANTI-FATIGUE COMPOSITION
#234Compositions and methods for increasing muscle mass and strength, treating skin, reducing wear and degradation from aging and exposure and improving recovery from stress such as exercise and trauma
#235PHARMACEUTICAL COMPOSITION COMPRISING IRON CHELATOR EXHIBITING ANTITUMOR ACTIVITY, ANTIBACTERIAL ACTIVITY AND/OR ANTIVIRUS ACTIVITY, AND HAVING REDUCED SIDE EFFECTS
#236Oral formulations of belinostat
#237Method of producing ergothioneine
#238Imidazole derivatives as formyl peptide receptor modulators
#239PERITONEAL DIALYSIS SOLUTION
#240Peptides for skin rejuvenation and methods of using the same
#241Methods of normalizing amino acid metabolism
#242Compositions prepared from poultry and methods of their use
#243N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides
#244Method of administration and treatment
#245Compositions and methods for the treatment of fat infiltration in muscle
#246Feed composition for improving intraintestinal environment
#247Food for improving intraintestinal environment
#248Formulations of VEG antagonist fusion proteins and method of manufacturing them
#249Compositions and methods for the treatment of hemoglobinopathies and thalassemias
#250Compositions for therapy and health containing amino acids with bitter taste
#251Method of administration and treatment
#252ANTI-FATIGUE COMPOSITION
#253METHODS OF AMELIORATING POST-DIALYSIS WASHOUT AND NUTRITIONAL SUPPLEMENTS FOR USE IN SUCH METHODS
#254Heat-stable dry powder pharmaceutical compositions and methods
#255Formulation for use in the treatment of uremic pruritus
#256METHODS AND COMPOSITIONS FOR THE SUSTAINED RELEASE OF CHROMIUM
#257IRE-1α inhibitors
#258NERIDRONIC ACID FOR TREATING COMPLEX REGIONAL PAIN SYNDROME
#259Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
#260Prevention or remediation composition for dementia or depression
#261Use of poultry crude protein extract for preparing anti-fatigue composition
#262PROTEIN HYDROLYSATES
#263NERIDRONIC ACID AND OTHER BISPHOSPHONATES FOR TREATING COMPLEX REGIONAL PAIN SYNDROME AND OTHER DISEASES
#264COMPOSITION FOR IMPROVING MUSCULAR ENDURANCE
#265Amino acid carbamate complexes
#266Compositions and methods for reducing reperfusion injury
#267Topical Compositions, Process of Manufacture and Method of Use
#268THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASES
#269NERIDRONIC ACID FOR TREATING COMPLEX REGIONAL PAIN SYNDROME
#270METHOD OF ADMINISTRATION AND TREATMENT
#271TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS BY INTRANASAL ADMINISTRATION OF IMMUNOGLOBULIN G
#272Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
#273Compositions for treatment of pain in patients who underwent elective anthroplasty
#274Methods and compositions for increasing the anaerobic working capacity in tissues
#275DOSAGE FORMS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE
#276ANTIVIRAL COMPOUNDS AND METHODS OF USE THEREOF
#277Synthesis of cyclocreatine and analogs thereof
#278Light-activated cation channel and uses thereof
#279Modified release orally administered amino acid formulations
#280Method for improving recognition and/or working memory in hyperphenylalanimenia and phenylketonuria patients
#281SKIN BARRIER ENHANCING ARTICLE AND MANUFACTURING METHOD
#282Compositions and methods for treatment of prediabetes
#283Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
#284METHOD FOR IMPROVING EQUILIBRIOCEPTION IN HEALTHY INDIVIDUALS AND NUTRITIONAL COMPOSITION
#285Production and use of bacterial histamine
#286Combination of TAFIa inhibitor with plasminogen activator
#287IRE-1α inhibitors
#288Heat-stable dry powder pharmaceutical compositions and methods
#289POLYNUCLEOTIDE COMPOSITIONS CONTAINING AMINO ACIDS
#290Method for treatment of humoral secretion dysfunctions
#291AMINO ACID COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUSCLE DISEASES AND DISORDERS
#292Healthful supplements
#293Modified release orally administered amino acid formulations
#294AMINO ACID COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUSCLE DISEASES AND DISORDERS
#295Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy
#296AMINO ACID SUPPLEMENTATION
#297THE COMPOSITIONS OF GLYCEROL AND /OR NON-TOXIC AMINO ACIDS FOR INHIBITING AND DESTROYING BIOFILM, INCLUDING RELATED METHODS
#298MATERIALS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
#299Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory Tract
#300Composition and method for treatment of symptoms associated with various skin conditions